Provecs Medical Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Provecs Medical General Information


Developer of a proprietary enviro adenoviral platform intended to provide novel treatment options for patients with advanced cancers and infectious diseases. The company's platform leverages technology to develop a versatile and cost-effective platform that locally delivers bio-molecules known to be non-tolerable in systemic use or impossible to manufacture, such as membrane proteins, short-lived cytokines, to provide clients with tumor gene therapy to expose the tumor to the immune system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Martinistraße 64
  • 20251 Hamburg
  • Germany
+49 040 000000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Provecs Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 28-Jul-2015 Completed Generating Revenue
3. Angel (individual) 01-Jan-2010 Completed Generating Revenue
2. Grant Completed Startup
1. Seed Round 03-Aug-2007 Completed Startup
To view Provecs Medical’s complete valuation and funding history, request access »

Provecs Medical Executive Team (4)

Name Title Board Seat Contact Info
Frank Schnieders Ph.D Founder & Chief Executive Officer
Andrea Miegel Head, Bioengineering and Qualoty Management
To view Provecs Medical’s complete executive team members history, request access »

Provecs Medical Board Members (1)

Name Representing Role Since
Herbert Stadler Ph.D Self Board Member 000 0000
To view Provecs Medical’s complete board members history, request access »

Provecs Medical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provecs Medical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elke Helftenbein Angel (individual) Minority 000 0000 000000 0
Peppermint Venture Partners Venture Capital Minority 000 0000 000000 0
Hamburg Innovation Foundation Government 000 0000 000000 0
To view Provecs Medical’s complete investors history, request access »